Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f7476704472769317bd2e5d3878ed47 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
filingDate |
2003-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1f1fcd7b68a85d6d7b0e86e2bd5967c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f21059459fe85d01c10032767634caef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eec576108ddf7c606d542dc377983c8 |
publicationDate |
2007-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1388542-B1 |
titleOfInvention |
Use of hederagenin 3-O-alpha-L-rhamnopyranosyl((1->2)-[beta-D-glucopyranosyl(1->4)]-alpha-L-arabinopyranoside or an extract from Pulsatillae radix containing the same as a therapeutic agent for solid tumors |
abstract |
This invention relates to a use of hederagenin 3-O- alpha -L-rhamnopyranosyl((1->2)-Ä beta -D-glucopyranosyl(1->4)Ü- alpha -L-arabinopyranoside or a Pulsatillae radix extract containing the same as a therapeutic agent for solid tumors. <IMAGE> |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005326850-B2 |
priorityDate |
2002-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |